Blog

Pulse Biosciences, Inc (PLSE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Integra LifeSciences (IART) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Similarweb (SMWB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Constellium (CSTM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Cellectar Biosciences, Inc. (CLRB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Investors might want to bet on Veris Residential (VRE), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

DPM Metals Inc. (DPMLF) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

JBT Marel (JBTM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Quanta Services, Inc. PWR has surged 36.3% in the past month, significantly outperforming the Zacks Engineering - R and D Services industry, the Zacks Construction sector and the S&P 500 Index. The

United Therapeutics UTHR reported first-quarter 2026 earnings per share (EPS) of $5.82, which missed the Zacks Consensus Estimate of $6.73. Earnings decreased 12% year over year.

United Therapeutics

Ford Motor Company F is reportedly in highly advanced discussions with Geely Automobile Holdings Limited (GELHY) over the potential sale of part of its Valencia manufacturing plant in Spain. The

Buoyed by a holistic growth model, Nokia Corporation NOK has gained 162.2% over the past year compared with the industry’s growth of 75.5%, outperforming peers like Comtech Telecommunications Corp

H&R Block Inc. HRB reported impressive third-quarter fiscal 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

HRB’s adjusted earnings of $6.02 per share beat the

RTX Corporation RTX stock has lost 11.3% in the past three months, underperforming both the Zacks Aerospace-Defense industry’s decline of 10.9% and the broader Zacks Aerospace sector’s decline of

An updated edition of the March 18, 2026, article.

Today’s world runs on data. Every online purchase, social media post, video stream, sensor reading and digital interaction adds to an enormous pool

Watts Water Technologies, Inc. WTS reported first-quarter 2026 adjusted earnings per share (EPS) of $3.04 compared with $2.37 in the prior-year quarter. The bottom line beat the Zacks Consensus

Radian Group Inc. RDN reported first-quarter 2026 adjusted operating income of $1.27 per share, which beat the Zacks Consensus Estimate by 8.5%. The bottom line improved 28.3% year over year.

International Business Machines Corporation IBM has declined 27% over the past six months against the industry’s growth of 60.7% due to macroeconomic challenges and a sudden development in the